FDA decision on Novavax’s Covid shots could be delayed to review changes in manufacturing

Must Read

The Food and Drug Administration said it needs to review changes to Novavax's manufacturing before deciding whether to authorize its Covid-19 vaccine in the U.S.The FDA's committee recommended the Novavax vaccine for use in the U.S. on Tuesday.The FDA is not obligated to follow the committee's recommendation, though the agency normally does so.

Latest News

Tesla factory in Germany gains approval to start commercial production

A Tesla Model Y is seen in a production hall of the Tesla Gigafactory during the open day. In...

More Articles Like This